Literature DB >> 31561377

Amyloid-β and Synaptic Vesicle Dynamics: A Cacophonic Orchestra.

Francesca Fagiani1,2, Cristina Lanni1, Marco Racchi1, Alessia Pascale1, Stefano Govoni1.   

Abstract

It is now more than two decades since amyloid-β (Aβ), the proteolytic product of the amyloid-β protein precursor (AβPP), was first demonstrated to be a normal and soluble product of neuronal metabolism. To date, despite a growing body of evidence suggests its regulatory role on synaptic function, the exact cellular and molecular pathways involved in Aβ-driven synaptic effects remain elusive. This review provides an overview of the mounting evidence showing Aβ-mediated effects on presynaptic functions and neurotransmitter release from axon terminals, focusing on its interaction with synaptic vesicle cycle. Indeed, Aβ peptides have been found to interact with key presynaptic scaffold proteins and kinases affecting the consequential steps of the synaptic vesicle dynamics (e.g., synaptic vesicles exocytosis, endocytosis, and trafficking). Defects in the fine-tuning of synaptic vesicle cycle by Aβ and deregulation of key molecules and kinases, which orchestrate synaptic vesicle availability, may alter synaptic homeostasis, possibly contributing to synaptic loss and cognitive decline. Elucidating the presynaptic mechanisms by which Aβ regulate synaptic transmission is fundamental for a deeper comprehension of the biology of presynaptic terminals as well as of Aβ-driven early synaptic defects occurring in prodromal stage of AD. Moreover, a better understating of Aβ involvement in cellular signal pathways may allow to set up more effective therapeutic interventions by detecting relevant molecular mechanisms, whose imbalance might ultimately lead to synaptic impairment in AD.

Entities:  

Keywords:  Amyloid-β; SNARE complex; intracellular signaling; neurotransmitter release; presynaptic function; synaptic vesicle cycle

Year:  2019        PMID: 31561377     DOI: 10.3233/JAD-190771

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  Hypoxic and Hypercapnic Responses in Transgenic Murine Model of Alzheimer's Disease Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and Rivastigmine.

Authors:  Kryspin Andrzejewski; Monika Jampolska; Ilona Mojzych; Silvia V Conde; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

Review 2.  Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics.

Authors:  Hyomin Jeong; Heewon Shin; Seungpyo Hong; YoungSoo Kim
Journal:  Exp Neurobiol       Date:  2022-04-30       Impact factor: 3.800

Review 3.  Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease.

Authors:  Pranesh Padmanabhan; Andrew Kneynsberg; Jürgen Götz
Journal:  Nat Rev Neurosci       Date:  2021-11-01       Impact factor: 34.870

4.  Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod.

Authors:  Henryk Jęśko; Iga Wieczorek; Przemysław Leonard Wencel; Magdalena Gąssowska-Dobrowolska; Walter J Lukiw; Robert Piotr Strosznajder
Journal:  Front Mol Neurosci       Date:  2021-07-09       Impact factor: 5.639

Review 5.  (Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis.

Authors:  Francesca Fagiani; Cristina Lanni; Marco Racchi; Stefano Govoni
Journal:  Front Mol Neurosci       Date:  2021-02-24       Impact factor: 5.639

6.  Amyloid Aβ25-35 Aggregates Say 'NO' to Long-Term Potentiation in the Hippocampus through Activation of Stress-Induced Phosphatase 1 and Mitochondrial Na+/Ca2+ Exchanger.

Authors:  Alexander V Maltsev; Anna B Nikiforova; Natalia V Bal; Pavel M Balaban
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

7.  Interaction of Aβ42 with Membranes Triggers the Self-Assembly into Oligomers.

Authors:  Siddhartha Banerjee; Mohtadin Hashemi; Karen Zagorski; Yuri L Lyubchenko
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.